Sansure Biotech Inc Total Liabilities

Latest as of June 2026: CN¥2.56 Billion CNY ≈ $374.89 Million USD

Sansure Biotech Inc total liabilities. Based on the latest financial reports, Sansure Biotech Inc (688289) has total liabilities worth CN¥2.56 Billion CNY (≈ $374.89 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Sansure Biotech Inc's assets to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Sansure Biotech Inc (2017–2025)

Total liabilities of Sansure Biotech Inc from 2017 to 2025. This chart illustrates how Sansure Biotech Inc's total liabilities have evolved over time, based on quarterly financial data.

Sansure Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Sansure Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Qisda Corp TW:2352	Taiwan	NT$151.80 Billion
Nations Technologies Inc SHE:300077	China	CN¥2.59 Billion
Zhongman Petro & Natural Gas SHG:603619	China	CN¥8.06 Billion
Dorchester Minerals LP NASDAQ:DMLP	USA	$4.32 Million
Sociedad Matriz SAAM SA SN:SMSAAM	Chile	CL$727.12 Million
Arlo Technologies NYSE:ARLO	USA	$216.06 Million
Polestar Automotive Holding UK PLC Class A ADS NASDAQ:PSNY	USA	$8.25 Billion
Accelevation Holdings Corp. Class A Ordinary Shares NASDAQ:ACCV	USA	$903.43 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Sansure Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Sansure Biotech Inc asset portfolio.

Liquidity & Leverage Metrics

Sansure Biotech Inc Total Liabilities Ratios Explained

Sansure Biotech Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.37	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.27	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sansure Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sansure Biotech Inc (2017–2025)

The table below shows the annual total liabilities of Sansure Biotech Inc from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥-7.22 Billion ≈ $-1.06 Billion	-673.93%
2024-12-31	CN¥1.26 Billion ≈ $184.09 Million	+22.22%
2023-12-31	CN¥1.03 Billion ≈ $150.62 Million	-38.03%
2022-12-31	CN¥1.66 Billion ≈ $243.05 Million	+134.26%
2021-12-31	CN¥709.03 Million ≈ $103.75 Million	+0.01%
2020-12-31	CN¥708.95 Million ≈ $103.74 Million	+734.17%
2019-12-31	CN¥84.99 Million ≈ $12.44 Million	-45.43%
2018-12-31	CN¥155.76 Million ≈ $22.79 Million	-16.54%
2017-12-31	CN¥186.62 Million ≈ $27.31 Million	--

About Sansure Biotech Inc

SHG:688289 China Medical Instruments & Supplies

Market Cap

$1.33 Billion

CN¥9.08 Billion CNY

Market Cap Rank

#7455 Global

#1597 in China

Share Price

CN¥15.79

Change (1 day)

-0.82%

52-Week Range

CN¥13.87 - CN¥22.12

All Time High

CN¥81.40